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Transbilayer phosphatidylethanolamine (PtdEtn) movements in the plasma membrane of Saccharo-
myces cerevisiae are regulated by an ATP-dependent, protein-mediated process(es). To examine whether
this process is influenced by the actin cytoskeleton, we have studied the PtdEtn translocation in S. cerevi-
siae cells after treatment with microfilament disrupting and microtubule-disrupting agents. PtdEtn translo-
cation was studied by measuring the external PtdEtn levels, using fluorescamine as the external membrane
probe, in the ATP-depleted, ATP-depleted and repleted, and N-ethylmaleimide-treated cells. The microfil-
aments and microtubules were disrupted by treatment with various cytochalasins and colchicine (or beno-
myl) respectively PtdEtn translocation became abnormal in the cytochalasin-treated cells but not in cells
that were treated with microtubule-disrupting agents, such as colchicine or benomyl. These results have
been interpreted to suggest that the actin cytoskeleton is involved in regulating the PtdEtn translocase
activity in the yeast cell plasma membrane.
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Transbilayer movement of membrane phospholipids is a fun- Earlier studies from our laboratory have shown that the ex-
ternal PtdEtn levels in the yeast cell plasma membrane are regu-damental process of cellular membrane biogenesis and cell
lated by an ATP-dependent, protein-mediated process(es) [6],growth [1, 2]. Although phospholipids, such as phosphatidic
which has been further confirmed by other investigators [7]. Inacid and phosphatidylglycerol can translocate spontaneously be-
continuation of this work, we have now examined the role, iftween the two leaflets of the membrane bilayer in their proton-
any, of the actin cytoskeleton in regulating the transbilayerated form, flip-flop of charged phospholipids, such as
PtdEtn distribution in the plasma membrane of yeast cells. Here,phosphatidylethanolamine (PtdEtn) and phosphatidylserine
we report that the external PtdEtn levels are significantly influ-(PtdSer), does not occur at an appreciable rate in artificial mem-
enced by disrupting the actin cytoskeleton in these cells.branes [2]. Nevertheless, transbilayer movement of phospholip-
ids must occur at considerable rates in membranes of living
cells, particularly those endowed with a lipid biosynthetic capa-
bility. MATERIALS AND METHODS
A number of hypotheses have been put forward concerning Materials. Yeast extract and mycological peptone (peptonethe mechanism of rapid flip-flop of lipids, but the most persua- M) were obtained from HiMedia Laboratories. Yeast Nitrogen
sive is the postulate that flip-flop is catalyzed by specific pro- Base was from Difco Laboratories. Fluorescamine, sodiumteins, termed as flippases or phospholipid translocases [2]. It is
azide, N-ethylmaleimide, digitonin, the ATP estimation kit (366-possible to define two broad classes of flippases those operating UV), cytochalasin B, D and E, benomyl and colchicine were
on phospholipids and glycolipids in biogeneic membranes, and purchased from Sigma Chemical Company.those operating at the plasma membranes of eukaryotic cells [2]. Yeast Strains and Growth Conditions. SaccharomycesWhile the former class appears to facilitate translocation of lip-
cerevisiae DBY 1690/3b strain (MatA, ade221, ACT1) is theids between the two leaflets without any apparent energy input, laboratory isolate, (haploid) from the diploid strain DBY 1690the latter class consists of the translocators that are driven by
which was a kind gift from Dr David Botstein (Stanford Univer-hydrolysis of ATP. Furthermore, numerous studies on blood cells sity, USA.) Cells were grown at 23°C in 1% mass/vol. yeast
suggest that the inner distributions of PtdEtn and PtdSer in mem-
extract, 2 % mass/vol. peptone M, 2% mass/vol. dextrose,branes could perhaps be stabilized by their interactions with the pH 5.5 (YEPD medium), and harvested at the late log phase.
underlying cytoskeletal proteins [1, 325]. Fluorescamine labeling. Late-log-phase cells were har-
vested by centrifuging at 10003g for 5 min (23 °C). The pellet
Correspondence to C. M. Gupta, Central Drug Research Institute, was washed once with 100 mM potassium phosphate, 5 mM
Chattar Manzil Palace, P.O. Box # 173, Lucknow-226 001, India EDTA, pH 7.2 (buffer A), and then with 100 mM potassium
Fax: 191 522 223405. phosphate, 600 mM potassium chloride, pH 8.2 (buffer B). CellsE-mail: root@cscdri.ren.nic.in
were suspended in buffer B to a density of 13108 cells/ml. AAbbreviations. PtdEtn, phosphatidylethanolamine; PtdSer, phospha-
cell suspension, equivalent to 63108 cells, was transferred to atidylserine; Me2SO, dimethylsulfoxide; TLC, thin-layer chromatogra-
25-ml glass conical flask and cooled to 10°C by gentle swirlingphy; CB, cytochalasin B; CD, cytochalasin D; CE, cytochalasin E.
for 10 min in a water bath maintained at 10°C. A solution ofNote. This work has been published as communication number 025/
97 from the Institute of Microbial Technology, Chandigarh, India. fluorescamine (about 0.8 M) in dry dimethylsulfoxide (Me2SO)
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Fig. 1. Labeling of yeast cells PtdEtn with fluorescamine. (a) Cells grown at 23°C were labeled (30 s) with 90 ìmol fluorescamine under various
conditions. Values shown are means of six determinations6SD. The inset shows the concentration dependent labeling of PtdEtn by fluorescamine.
(b) Fluorescence micrographs of yeast cells labeled with fluorescamine at 10°C (A), 37°C (B), and 10°C after permeabilization with digitonin (C).
was added dropwise with constant swirling over 30 s. The reac- (Difco), 2 % dextrose; pH 5.5, and to it was added cytochalasin
B (CB), cytochalasin D (CD) or cytochalasin E (CE) in Me2SOtion was stopped by the addition of equal volumes of 1 M am-
monia solution in 600 mM potassium chloride. The suspension to a final concentration of 40 ìg/ml. Equal volume of Me2SO
(,1% always) was added to the control cells. The mixture waswas centrifuged in a RC-5 C centrifuge (Sorvall instruments) at
20003g (2°C) and the pellet was washed four times with incubated for 3 h at 23°C. The cells were harvested, washed
with buffer A and then processed for fluorescamine labeling.200 mM potassium acetate, 600 mM potassium chloride; pH 4.5
(buffer C) till the supernatant was free of color. Cytochalasin E treatment. In a separate set of experiments,
the cells were treated with different concentrations of CE andFor the labeling of total cellular aminophospholipids in yeast
cells, the cells were made leaky by vortexing with 0.5% digi- external PtdEtn was estimated. Typically, 13108/ml cells were
suspended in 0.67 % yeast nitrogen base, 2% dextrose, pH 5.5,tonin for 30 min at 30°C in an Eppendorf vibrato-mixer [8],
then processed for fluorescamine labeling. medium and to it was added CE in Me2SO to final concentra-
tions of 5, 10, 15, 20 and 40 ìg/ml separately. Equal volumesLipids were extracted using 2 :1 (by vol.) chloroform/metha-
nol [9] and individual phospholipid components were separated of Me2SO were added to the control cells. The mixtures were
incubated for 3 h at 23°C. Portions of the cell suspension wereby two-dimensional TLC on coated aluminium-backed silica gel
G-60 plates (Merck), as described earlier [6]. The plates were taken out after CE treatment, washed with 0.67% yeast nitrogen
base, 2% dextrose, pH 5.5, and incubated without any drug forstained with iodine vapors and the spots corresponding to the
various phospholipids cut out carefully. Lipid phosphate was es- another 3 h at 23°C. The cells were harvested, washed with
buffer A, then processed for fluorescamine labeling.timated according to the method of Bartlett [10].
N-Ethylmaleimide/sodium azide treatments. Cells Effect of ATP depletion/repletion in cytochalasin-treated
cells. Cells (13108/ml) were treated first with CE (10 g/ml) as(23108) were treated with 9 mM N-ethylmaleimide or 20 mM
sodium azide following the published procedure [6], then pro- described above, then incubated in 0.67% yeast nitrogen base,
2% dextrose, pH 5.5, in the presence of 20 mM sodium azidecessed for fluorescamine labeling.
Cellular ATP depletion and repletion. For the depletion of (3 h, 23°C) as well as in its absence (16 h, 23°C), as described
above. A small portion of the cells, after 16 h incubation, wastotal cellular ATP pools, cells were incubated in 0.67 % yeast
nitrogen base (Difco), 2% sorbitol, pH 5.5 (Difco) for 16 h at washed with 0.67% yeast nitrogen base, 2% dextrose, pH 5.5,
and incubated for 3 h at 23°C to replete the cellular ATP. The23°C. To it was added 2 % dextrose and the mixture incubated
for another 3 h at 23°C to replete the cellular ATP pools. Sam- cells harvested after CE treatment, sodium azide treatment, ATP
depletion and ATP repletion were washed with buffer A, thenples (about 23108 cells) were taken out at 0 h depletion, 16 h
depletion and after 3 h repletion, and processed for fluorescam- processed for fluorescamine labeling.
In another set of experiments, the cells were treated with CEine labeling as described above.
ATP levels in cells were estimated using Sigma ATP estima- (5 ìg/ml) followed by ATP depletion and repletion, then pro-
cessed for fluorescamine labeling.tion kit (procedure no. 366-UV).
Treatment with microfilament disrupting agents. Cells Treatment with microtubule-disrupting agents. Cells
(13108/ml) were suspended in 0.67% yeast nitrogen base, 2%(13108/ml) were suspended in 0.67% yeast nitrogen base
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Fig.3. Microfilament disruption leads to the decreased accessibility
of the external PtdEtn to fluorescamine. Cells grown at 23°C were
treated with various cytochalasins for 3 h, then labeled with fluorescam-Fig. 2. ATP depletion and N-ethylmaleimide treatment decrease the
ine. Open bars, cells prior to cytochalasin treatment; solid bars, cellsaccessibility of external PtdEtn to fluorescamine. Cells grown at 23°C
after cytochalasin treatment. Values are means of several determinationswere treated with 20 mM sodium azide or incubated in 0.67% yeast
6SD. Numbers shown in parentheses denote the number of determi-nitrogen base, 2% sucrose for depleting the cellular ATP or treated with
nations.N-ethylmaleimide for modification of protein sulfhydryl groups, then
labeled with fluorescamine. The ATP-depleted cells were repleted with
ATP by further incubation in 0.67% yeast nitrogen base, 2% sucrose,
containing 2% dextrose, for 3 h. The cellular ATP levels after the sodium
azide treatment and metabolic depletion were less than 10% of the initial
levels. Open bars, cells without treatment; shaded bars, cells after ATP
depletion or N-ethylmaleimide (NEM) treatment; solid bars, ATP-de-
pleted cells after ATP repletion. Values are means of several determi-
nations6SD. Numbers shown in parentheses denote the number of de-
terminations. (A) shows the cellular ATP levels at various time points
(B) shows the concentration-dependent effect of the N-ethylmaleimide
(NEM) treatment on accessibility of external PtdEtn to fluorescamine.
dextrose, pH 5.5, and then treated separately with benomyl
(50 ìg/ml) and colchicine (5 mg/ml) in Me2SO for 4 h and 6 h,
at 23°C. Equal volume of Me2SO was added to the control cells.
The cells were harvested, washed with buffer A and processed
for fluorescamine labeling.
Viability Measurement. A portion of the cell suspension
was taken out before fluorescamine labeling in each experiment.
The cells were washed and suspended in methylene blue dye
solution as described earlier [11]. Blue-stained cells were con-
sidered as dead cells and counted using haemocytometer to ex-
Fig.4. CE treatment brings about a reversible reduction in the exter-press their viability.
nal PtdEtn levels. Cells grown at 23°C, treated with CE (10, 20 andFluorescence microscopy. Cells labeled with fluorescamine, 40 ìg/ml) for 3 h, then labeled with fluorescamine. A portion of the
after various treatments as described above, were spread over cells was washed twice with 0.67% yeast nitrogen base, 2% sucrose and
poly-L-lysine-coated glass slides and mounted under coverslip. incubated without any drug for another 3 h, then processed for fluores-
They were viewed under Leica (Wild Leitz) fluorescence micro- camine labeling. Control cells were incubated for 6 h under identical
scope. Photographs were taken using Kodak ASA 400 film. conditions. At least 96% cells were viable in each case under these
experimental conditions. Solid bars, cells prior to CE treatment; open
bars, cells after CE treatment; shaded bars, CE-treated cells further incu-
bated in CE-free 0.67% yeast nitrogen base, 2% sucrose. Values areRESULTS means of 628 determinations6SD. Inset, concentration-dependent ef-
fect of CE on the accessibility of the external PtdEtn to fluorescamine.Fluorescamine has been used to determine the aminophos- Values are means of 8210 determinations6SD.pholipid distribution in membranes of different cell types [122
14]. Earlier studies from our laboratory have shown that the flu-
orescamine can selectively modify the PtdEtn located in the was modified at 10°C, about 75280% of this phospholipid was
outer surface of the intact yeast cells [6]. Selection of this rea- labeled by fluorescamine at 37°C or upon permeabilizing the
gent to probe the external aminophospholipids was based on the cells with digitonin (Fig. 1a). These results clearly establish the
fact that the cytoplasmic pH (<6.6) in the yeast cells [15] is suitability of fluorescamine as an external membrane probe to
significantly lower than the optimal pH (<8.0) required for the determine the aminophospholipid (especially PtdEtn) distribu-
fluorescamine labeling [16]. To further establish that this reagent tion in the yeast cells.
does modify only the external PtdEtn in the yeast cell plasma
membrane, the intact cells were labeled with fluorescamine at Characterization of the PtdEtn translocation process across
the yeast plasma membrane. Earlier studies have demonstrated10°C, 37°C and 10°C, but after permeabilizing the cells with
digitonin (Fig. 1). Whereas only about 6.6% of the total PtdEtn the involvement of an ATP-dependent, protein-mediated pro-
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Fig. 5. Reversible depletion of metabolic stores in CE-treated cells
brings about a reversible reduction in the external PtdEtn levels.
Cells grown at 23°C were incubated in 0.67% yeast nitrogen base, 2% Fig.6. Microtubule-disrupting reagents do not cause any change in
sucrose with CE (5 ìg/ml) for 3 h. The CE-treated cell suspension was the external PtdEtn levels. Cells grown at 23°C were incubated in
divided into five equal parts. These were washed and given treatments 0.67% yeast nitrogen base, 2% sucrose with benomyl or colchicine and
separately. (j) Cells incubated without any treatment for 24 h; (s) cells then labeled with fluorescamine. The cell viability after drug treatment
after 3 h CE-treatment ; (_) CE-treated cells after 16 h ATP depletion in was at least 95%. Open bars, cells prior to drug treatment; solid bars,
the presence of CE; (‘) CE-treated and ATP-depleted cells after 3 h cells after drug treatment. Values are means of several determinations
ATP repletion in the presence of CE; (r) CE-treated and ATP depleted/ 6SD. Numbers shown in parentheses denote the number of determi-
repleted cells incubated further in CE-free 0.67 % yeast nitrogen base, nations.
2% sucrose ; (h) cells after 24 h CE treatment. Values are means of 62
8 determinations6SD. Similar results were observed when cells treated
with CE for 3 h were depleted and depleted/repleted of ATP in the ab- cause of some nonspecific effects of CE on the cells, was estab-
sence of CE. No difference in phospholipid compositions were observed lished by observing the near normal PtdEtn distribution afterin the cells incubated under various conditions.
removing CE from the incubation medium (Fig. 4). However,
the PtdEtn distribution could not be reversed in the cells that
were treated with a high CE concentration (40 ìg/ml).cess(es) in regulation of PtdEtn distribution across the plasma
Effect of ATP depletion/repletion on the external PtdEtnmembrane bilayer of the S. cerevisiae A184D cells [6]. To exam-
levels in the CE-treated cells. To examine whether the PtdEtnine whether S. cerevisiae DBY 1690/3b cells possess a similar
levels could be further reduced in the CE-(5 ìg/ml)-treated cellsPtdEtn-translocation process, the PtdEtn distribution was ana-
by depleting the cellular ATP, the cytochalasin-treated cells werelysed in ATP-depleted, ATP-depleted and repleted, and N-ethyl-
subjected to sodium azide or starved both in the presence andmaleimide-treated cells. The ATP depletion was carried out by
absence of CE (5 ìg/ml), then the outer PtdEtn levels analyzed.both sodium azide treatment and metabolic starvation. The
The PtdEtn levels decreased to about 50% after depleting theamounts of external PtdEtn decreased by 40250% after treating
cells of ATP (Fig. 5). The external PtdEtn levels, however, re-the cells with sodium azide (Fig. 2). Similar results were ob-
turned to their original levels by repleting the cells of ATP. Fromserved when the cells were depleted of ATP by metabolic starva-
these results, we infer that the biochemical loci affected by thetion (Fig. 2). The external PtdEtn levels in the ATP-depleted
ATP depletion and CE treatments are plausibly the same.cells could, however, be restored to near normal by repleting the
cells of ATP (Fig. 2). These results strongly indicate that the
Effect of microtubule-disrupting agents on the outer plasmaPtdEtn distribution in these cells is regulated by an ATP-depen-
membrane PtdEtn levels. To further examine whether the ob-dent process(es). That this process is mediated by some protein-
served decrease in PtdEtn levels in the cytochalasin-treated cellslike factor(s) was revealed by our observation that the external
is caused by disruption of the microfilaments only, the PtdEtnPtdEtn levels were decreased by 60270% after treating the distribution was examined in yeast cells that were treated withcells with the sulfhydryl-modifying reagent, N-ethylmaleimide
microtubule-disrupting agents, namely benomyl and colchicine(Fig. 2). [21224]. The microtubule disruption did not significantly affect
the external PtdEtn levels in the yeast cells (Fig. 6).Effect of cytoskeleton-disrupting agents on the PtdEtn distri-
bution. Effect of actin filament-disrupting agents (cytochala-
sins) on outer plasma membrane PtdEtn levels. Cytochalasins DISCUSSIONShave been extensively used to disrupt the actin cytoskeleton in
a variety of eukaryotic cells [17, 18]. These compounds not only Various phospholipids in biological membranes are dif-
ferentially distributed in the two-halves of the membrane bilayer.induce depolymerization of actin filaments, but also prevent
their growth [19]. We therefore considered it of interest to ana- While the choline-containing phospholipids tend to localize
mainly in the outer monolayer, the aminophospholipids are pre-lyze the PtdEtn distribution in the yeast cells that were treated
with various cytochalasins (Fig. 3). The external PtdEtn levels sent largely in the inner monolayer [1]. Since about 60% of the
total phospholipids have been reported to belong to the yeastdecreased by at least 50% in the yeast cells that were treated
with CB, CD or CE. Furthermore, no decrease in the ATP levels cell plasma membrane [25228], present results indicate that
about 90% of the total plasma membrane PtdEtn is present in[20] and total phospholipid compositions were observed in the
CB-treated cells (data not shown). the inner monolayer and that the remaining 10% is present in
the outer monolayer, which is consistent with earlier findingsTo examine whether the cytochalasins produce concentra-
tion-dependent effects on the outer membrane PtdEtn levels, the [6, 29]. Furthermore, it reconfirms that the transbilayer PtdEtn
movements in the yeast cell plasma membrane are regulated bycells were treated with different concentrations of CE. The exter-
nal PtdEtn levels gradually decreased with an increase in the CE an ATP-dependent, protein-mediated process(es). However, un-
like earlier study [29], we could not detect PtdSer in the externalconcentration. That this decrease in the PtdEtn levels is not be-
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tion of fluorescent labeled phosphatidylethanolamine is controlledsurface of the DBY 1690/3b cells under our experimental condi-
by transcriptional regulators, PDR1 and PDR3, J. Cell Biol. 138,tions.
2552270.This study shows that a treatment with microfilament-dis-
8. Cordeiro, C. & Freire, A. P. (1995) Digitonin permeabilization ofrupting agents, such as cytochalasins [17219], leads to a Saccharomyces cerevisiae cells for in situ enzyme assay, Anal.decrease in external PtdEtn levels in yeast cells. However, no Biochem. 229, 1452148.
such decrease was observed when the cells were treated with 9. Folch, J., Less, M. & Sloane-Stanley, G. H. (1957) A simple method
microtubule-disrupting agents such as colchicine [21, 22] or be- for the isolation and purification of total lipids from animal tissue,
nomyl [23, 24]. That the decreased external PtdEtn levels in the J. Biol. Chem. 226, 4972509.
10. Bartlett, G. R. (1959) Phosphorous assay in column chromatogra-CE-treated cells cannot arise from some nonspecific effects of
phy, J. Biol. Chem. 234, 4662468.CE on the cells, at least at low concentrations, is confirmed by
11. Thomas, K. C. & Ingledew, W. M. (1990) Fuel alcohol production:the observation that these levels could be brought back to near
effects of free amino nitrogen on fermentation of very high grav-normal by removing the drug from the incubation medium. From
ity wheat mashes, Appl. & Environ. Microbiol. 56, 204622048.these results, we infer that the alterations caused by CE in the
12. Chandra, R., Joshi, P., Bajpai, V. K. & Gupta, C. M. (1987) Mem-
actin cytoskeleton directly or indirectly influence the transbi- brane phospholipid organization in calcium loaded human eryth-layer PtdEtn movements across the yeast plasma membrane bi- rocytes, Biochim. Biophys. Acta 902, 2532262.
layer. 13. Gudi, S. R. P., Kumar, A., Bhakuni, V., Gokhale, S. M. & Gupta,
It would seem that the actin cytoskeleton modifications af- C. M. (1990) Membrane skeleton-bilayer interactions is not the
major determinant of membrane phospholipid asymmetry in hu-fect the ATP-dependent PtdEtn translocase activity in the yeast
man erythrocytes, Biochim. Biophys. Acta 1023, 63272.cells. This finds strong support from our observation that the
14. Frank, P. F. H., Op den Kamp, J. A. F., Roelofsen, B. & van Deenen,decreased external PtdEtn levels in the CE-treated, ATP-de-
L. L. M. (1986) Does diamide treatment of intact human erythro-pleted cells could be restored back to normal by repleting the
cytes cause a loss of phospholipid asymmetry, Biochim. Biophys.cells of ATP followed by CE removal (Fig. 6). In our earlier Acta, 857, 1272130.
study, we proposed that the steady-state PtdEtn levels in the 15. Slavik, J. & Kotyk, A. (1984) Intracellular pH distribution and trans-
yeast cell plasma membrane are perhaps maintained by the ATP- membrane pH profile of yeast cells, Biochim. Biophys. Acta 766,
dependent out-to-in (pump I) and in-to-out (pump II) pumps [6]. 6792684.
While pump I was envisaged to be of high affinity, and ATP- 16. Udenfriend, S., Stein, S., Bohlen, P., Dairman, W., Lwimgruber,
W. & Weigele, M. (1972) Fluorescamine: a reagent for assay ofdependent, N-ethylmaleimide insensitive, pump II was consid-
amino acid, peptides, proteins, and primary amines in picomoleered to be of low affinity, ATP-dependent, and N-ethylmaleimide
range, Science 178, 871.sensitive. In light of this model, we suggest that CE-induced
17. Cooper, J. A. (1987) Effects of cytochalasin and phalloidin on actin,actin cytoskeleton changes should selectively affect pump II.
J. Cell Biol. 105, 147321478.This is based on the following considerations: (a) The Effect on
18. Maclean-Fletcher, S. & Pollard, T. D. (1980) Mechanism of actionboth pumps should lead to either the symmetric PtdEtn distribu-
of cytochalasin B on actin, Cell 20, 3292341.
tion across the plasma membrane bilayer or freeze the original 19. Yahara, I., Harada, F., Sukha, S., Yoshira, K. & Natori, S. (1982)
steady state; (b) the selective effect on the pump I must result Correlation between effects of 24 different cytochalasins on cellu-
in an increase in the external PtdEtn levels. lar structures and cellular events and those on actin in vitro, J.
Cell Biol. 92, 69278.In conclusion, the present study indicates that the in-to-out
20. Rampal, A. L. H., Pinokofsky & Jung, C. Y. (1980) Structure ofPtdEtn translocase activity is perhaps directly/indirectly influ-
cytochalasins and cytochalasin B binding site in human erythro-enced by the actin cytoskeleton at least in the yeast cell plasma
cyte membranes, Biochemistry 19, 6792683.membrane. This means that the structural changes induced in the
21. Varma, J. K. & Sackett, D. L. (1993) Molecular mechanism of col-
membrane-associated cytoskeleton could influence the exteranl
chicine action: Induced local unfolding of â-tubulin, BiochemistryPtdEtn levels by modifying the in-to-out PtdEtn translocase ac- 32, 13 560213565.
tivity in cells. 22. Vashishta, R. K. & Kaushal, B. (1983) Effects of colchicine in
Saccharomyces cerevisiae, Indian J. Exp. Biol. 21, 3672370.
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